Remleas

Remleas Indications/Uses

valbenazine

Manufacturer:

Neurocrine Biosciences

Distributor:

Pharmaforte

Marketer:

Mitsubishi Tanabe Pharma
Full Prescribing Info
Indications/Uses
REMLEAS is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with tardive dyskinesia.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in